First Time Loading...

Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319

Watchlist Manager
Chengdu Olymvax Biopharmaceuticals Inc Logo
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
Watchlist
Price: 9.63 CNY 1.05%
Updated: May 29, 2024
Section:
 

Relative Value

The Relative Value of one Chengdu Olymvax Biopharmaceuticals Inc stock under the Base Case scenario is 15.3 CNY. Compared to the current market price of 9.63 CNY, Chengdu Olymvax Biopharmaceuticals Inc is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
15.3 CNY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.1
P/S
P/S
Price to Sales
7.1
vs History
94
vs Industry
56
Median 3Y
14.4
Median 5Y
14.4
Industry
8
Forward
6
More Details
161.7
P/E
P/E
Price to Earnings
161.7
vs History
62
vs Industry
1
Median 3Y
170.7
Median 5Y
170.7
Industry
26.3
Forward
59.5
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-65
Median 5Y
-65
Industry
23.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-60.2
Median 5Y
-60.2
Industry
23.2
More Details
4.3
P/B
P/B
Price to Book Value
4.3
vs History
94
vs Industry
22
Median 3Y
8.6
Median 5Y
8.6
Industry
2.5
More Details
6.8
EV/S
EV/S
Enterprise Value to Sales
6.8
vs History
94
vs Industry
47
Median 3Y
13.7
Median 5Y
13.7
Industry
7.1
Forward
5.7
More Details
7.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.4
vs History
94
vs Industry
47
Median 3Y
14.7
Median 5Y
14.7
Industry
8.6
More Details
120.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
120.6
vs History
75
vs Industry
1
Median 3Y
144.5
Median 5Y
144.5
Industry
4.8
Forward
25.8
More Details
120.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
120.6
vs History
75
vs Industry
1
Median 3Y
144.5
Median 5Y
144.5
Industry
4.7
Forward
102.5
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-63
Median 5Y
-63
Industry
6.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-39.8
Median 5Y
-39.8
Industry
3.9
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
94
vs Industry
40
Median 3Y
7.4
Median 5Y
7.4
Industry
4.6
More Details

Multiples Across Competitors

Competitors Multiples
Chengdu Olymvax Biopharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
3.9B CNY 7.1 161.7 120.6 120.6
US
Abbvie Inc
NYSE:ABBV
274.3B USD 5 46.1 13 20
US
Amgen Inc
NASDAQ:AMGN
161B USD 5.5 42.8 18.2 30
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.4B USD 11.3 28.7 24.1 25.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.2B USD 8.2 27.8 22.5 24.9
AU
CSL Ltd
ASX:CSL
135.6B AUD 6.4 36.5 22 27.3
US
Gilead Sciences Inc
NASDAQ:GILD
79.7B USD 2.9 164.6 8.4 11
US
Moderna Inc
NASDAQ:MRNA
58.7B USD 11.4 -9.8 -11.1 -9.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.8B USD 3.3 27.3 14 17.5
KR
Celltrion Inc
KRX:068270
36.9T KRW 15.9 93.9 47.3 79

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.